Search

everythinglearnresearchcommunity

for

Search:↓

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

PRP preservation improves hair transplant results better than saline.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Low PON1 levels may indicate and predict the severity of hair loss.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Aromatase gene variation may increase female hair loss risk.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

New scale reliably assesses male hair loss with female pattern.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Temporal hair loss relates to overall scalp hair loss in women.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

The 675 nm laser treatment significantly increased hair density and reduced symptoms of androgenetic alopecia in both men and women, with no side effects.

Female pattern baldness may indicate a higher risk of coronary artery disease.